This company has been acquired
Iteris Valuation
Is ITI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ITI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ITI ($7.19) is trading above our estimate of fair value ($0.07)
Significantly Below Fair Value: ITI is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ITI?
Key metric: As ITI is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ITI's PS Ratio? | |
|---|---|
| PS Ratio | 1.8x |
| Sales | US$174.22m |
| Market Cap | US$309.47m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.7x |
| Enterprise Value/EBITDA | 34.7x |
| PEG Ratio | 2.2x |
Price to Sales Ratio vs Peers
How does ITI's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.1x | ||
VPG Vishay Precision Group | 0.9x | 1.4% | US$292.4m |
FARO FARO Technologies | 1.5x | 2.1% | US$510.8m |
SMRT SmartRent | 1.6x | 7.4% | US$310.0m |
TROO TROOPS | 48.4x | n/a | US$172.7m |
ITI Iteris | 1.8x | 11.9% | US$309.5m |
Price-To-Sales vs Peers: ITI is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (17.1x).
Price to Sales Ratio vs Industry
How does ITI's PS Ratio compare vs other companies in the US Electronic Industry?
Price-To-Sales vs Industry: ITI is good value based on its Price-To-Sales Ratio (1.8x) compared to the US Electronic industry average (2x).
Price to Sales Ratio vs Fair Ratio
What is ITI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.8x |
| Fair PS Ratio | 1.1x |
Price-To-Sales vs Fair Ratio: ITI is expensive based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | US$7.10 0% | 1.4% | US$7.20 | US$7.00 | n/a | 2 |
| Nov ’25 | US$7.19 | US$7.10 -1.3% | 1.4% | US$7.20 | US$7.00 | n/a | 2 |
| Oct ’25 | US$7.15 | US$7.10 -0.7% | 1.4% | US$7.20 | US$7.00 | n/a | 2 |
| Sep ’25 | US$7.05 | US$7.10 +0.7% | 1.4% | US$7.20 | US$7.00 | n/a | 2 |
| Aug ’25 | US$4.55 | US$9.00 +97.8% | 24.0% | US$12.00 | US$7.00 | n/a | 3 |
| Jul ’25 | US$4.25 | US$9.00 +111.8% | 24.0% | US$12.00 | US$7.00 | n/a | 3 |
| Jun ’25 | US$4.53 | US$7.70 +70.0% | 25.8% | US$11.00 | US$5.00 | n/a | 5 |
| May ’25 | US$4.54 | US$7.70 +69.6% | 25.8% | US$11.00 | US$5.00 | n/a | 5 |
| Apr ’25 | US$4.85 | US$6.88 +41.8% | 18.1% | US$8.50 | US$5.00 | n/a | 4 |
| Mar ’25 | US$5.17 | US$6.88 +33.0% | 18.1% | US$8.50 | US$5.00 | n/a | 4 |
| Feb ’25 | US$4.90 | US$6.00 +22.4% | 11.8% | US$7.00 | US$5.00 | n/a | 4 |
| Jan ’25 | US$5.20 | US$6.00 +15.4% | 11.8% | US$7.00 | US$5.00 | n/a | 4 |
| Dec ’24 | US$4.27 | US$6.00 +40.5% | 11.8% | US$7.00 | US$5.00 | n/a | 4 |
| Nov ’24 | US$4.39 | US$6.00 +36.7% | 11.8% | US$7.00 | US$5.00 | US$7.19 | 4 |
| Oct ’24 | US$4.14 | US$6.00 +44.9% | 11.8% | US$7.00 | US$5.00 | US$7.15 | 4 |
| Sep ’24 | US$4.67 | US$6.00 +28.5% | 11.8% | US$7.00 | US$5.00 | US$7.05 | 4 |
| Aug ’24 | US$4.13 | US$5.50 +33.2% | 20.3% | US$7.00 | US$4.00 | US$4.55 | 4 |
| Jul ’24 | US$3.96 | US$5.50 +38.9% | 20.3% | US$7.00 | US$4.00 | US$4.25 | 4 |
| Jun ’24 | US$4.52 | US$5.38 +18.9% | 22.2% | US$7.00 | US$4.00 | US$4.53 | 4 |
| May ’24 | US$4.43 | US$5.38 +21.3% | 22.2% | US$7.00 | US$4.00 | US$4.54 | 4 |
| Apr ’24 | US$4.69 | US$5.13 +9.3% | 17.4% | US$6.00 | US$4.00 | US$4.85 | 4 |
| Mar ’24 | US$4.69 | US$5.13 +9.3% | 17.4% | US$6.00 | US$4.00 | US$5.17 | 4 |
| Feb ’24 | US$3.74 | US$4.50 +20.3% | 28.3% | US$6.00 | US$3.00 | US$4.90 | 4 |
| Jan ’24 | US$3.11 | US$4.50 +44.7% | 28.3% | US$6.00 | US$3.00 | US$5.20 | 4 |
| Dec ’23 | US$3.14 | US$4.50 +43.3% | 28.3% | US$6.00 | US$3.00 | US$4.27 | 4 |
| Nov ’23 | US$2.99 | US$5.67 +89.5% | 54.6% | US$10.00 | US$3.00 | US$4.39 | 3 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Gauzy
US$147.5m
An integrated light and vision control company, develops, manufactures, and supplies liquid crystal controllers and films in Israel, the United States, Europe, France, Asia, and internationally.
GAUZ
US$7.89
7D
11.6%
1Y
n/a
VerifyMe
US$6.5m
Provides traceability and customer support services through software and process technology.
VRME
US$0.62
7D
-37.2%
1Y
-38.9%
Diebold Nixdorf
US$1.7b
Engages in the automating, digitizing, and transforming the way people bank and shop worldwide.
DBD
US$45.69
7D
10.6%
1Y
79.6%